ACE and chronic kidney disease: This study revealed that the continuation of the ACE inhibitor/ARB medications is not associated with significant renal injury in older patients with CKD stages 2-5 baseline renal disease undergoing coronary angiography. These results suggest that patients can continue ACE inhibitor/ARB medications during and after cardiac catheterization procedures provided that no intercurrent illness dictates an alternative plan.